Research suggests that the use of antacids, also known as acid-suppression therapy, may be associated with a higher risk of migraines and severe headaches. Some studies have found a link between proton pump inhibitors and an increased risk of these types of headaches. The relationship between acid-reflux drugs and migraine risk appears to be supported by various findings, although the extent of this connection is still being explored.